[EO-01] Platform Session 01：Neuromuscular Disorders 1

[EO-006] Could Nusinersen from the neonatal period prevent the development of spinal muscular atrophy?

Sassa Kaori^1,5，Ohtaki Satomi^1,5，Teranishi Hiromi^1,5，Namba Akira^2,3,5，Tsuruoka Megumi^2,5，Kunikata Tetsuya⁴，Ohtake Akira^1,2,6，Yamanouchi Hideo^1,5 (1. Departments of Pediatrics, Saitama Medical University Hospital, Saitama, Japan，2. Clinical Genomics, Saitama Medical University Hospital, Saitama, Japan，3. Obstetrics and Gynecology, Saitama Medical University Hospital, Saitama, Japan，4. Neonatology, Saitama Medical University Hospital, Saitama, Japan，5. Comprehensive Epilepsy Center, Saitama Medical University Hospital, Saitama, Japan.，6. Center for Intractable Diseases, Saitama Medical University Hospital, Saitama, Japan.)